Fareston (KYOWA KIRIN, INC,)
Welcome to the PulseAid listing for the Fareston drug offered from KYOWA KIRIN, INC,. This Estrogen Agonist/Antagonist [EPC],Selective Estrogen Receptor Modulators [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | KYOWA KIRIN, INC, |
NON-PROPRIETARY NAME: | toremifene citrate |
SUBSTANCE NAME: | TOREMIFENE CITRATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Estrogen Agonist/Antagonist [EPC],Selective Estrogen Receptor Modulators [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1997-06-30 |
END MARKETING DATE: | 0000-00-00 |
Fareston HUMAN PRESCRIPTION DRUG Details:
Item Description | Fareston from KYOWA KIRIN, INC, |
LABELER NAME: | KYOWA KIRIN, INC, |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 60(mg/1) |
START MARKETING DATE: | 1997-06-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 42747-327_2009e5ef-6524-4b62-b34f-145e63c371c4 |
PRODUCT NDC: | 42747-327 |
APPLICATION NUMBER: | NDA020497 |
Other TOREMIFENE CITRATE Pharmaceutical Manufacturers / Labelers: